Zenosense, Inc. (ZENO) Posts Test Results, Now Trading on OTCQB Venture Market
Second round of testing for MIDS Cardiac™ detection technology for cardiac emergency triage reveals breakthrough quantitative testing results American Heart Association projects that 130 million adults in the U.S. will have some form of cardiovascular disease by 2035, with total costs expected to reach $1.1 trillion Studies performed outside the United States have demonstrated that high-sensitivity troponin testing speeds the triage of patients with suspected acute myocardial infarction (AMI, “Heart Attack”) Identifying low levels of troponin using a rapid-response, handheld diagnostic device for cardiac emergency triage can speed the treatment of AMI and improve treatment outcomes Identifying a low-risk patient could permit…